Today, the European Commission officially approved the acquisition of Catalent, Inc. by Novo Holdings A/S, a deal that will further expand the capabilities of the Novo Group. Catalent, a global leader in contract development and manufacturing services based in New…
Eli Lilly has unveiled promising data from its Phase IIIb SURMOUNT-5 study, showing that its weight loss treatment, Zepbound (tirzepatide), outperforms Novo Nordisk’s Wegovy (semaglutide) in terms of weight reduction. At the 72-week mark, Zepbound patients lost an average of…
If public transportation is your ticket to holiday cheer, it’s vital to take precautions to avoid illness while en route. Hand hygiene is your first line of defense during the holidays, says Toothman. Keep your hands clean by washing frequently…
CVS Health has announced two key leadership appointments to further strengthen its Pharmacy and Consumer Wellness division. Len Shankman has been appointed as president of Pharmacy and Consumer Wellness (PCW), and Lucille Accetta, RPh, MPH, MBA, has been named the…
Common cold viruses cause substantial productivity losses and negatively impact overall well-being, with an estimated $40 billion lost annually in the United States alone. However, a new study published in the peer-reviewed journal PLOS ONE suggests that Biovanta could significantly…
Revolution Medicines a clinical-stage oncology company developing targeted therapies for RAS-driven cancers, announced significant clinical updates from its RAS(ON) inhibitor portfolio. The data, presented during an investor webcast, focused on the Phase 1 RMC-6236 monotherapy study in pancreatic ductal adenocarcinoma…
Orion ensures a steady supply of medicines by manufacturing them in its own facilities, while its subsidiary Fermion produces the active pharmaceutical ingredients (APIs) for these medicines. This integrated production in Finland strengthens the availability of essential medicines not only…
Technological breakthroughs and deeper insights into glioblastoma are revitalizing efforts to tackle this aggressive brain tumor. Companies like Merck, Kazia Therapeutics, CorriXR Therapeutics, and others are leading the charge, raising optimism for patients after years of limited progress. A Turning…
At the 2024 Annual Meeting of the Radiological Society of North America (RSNA), held December 1-4 in Chicago, GE HealthCare (Nasdaq: GEHC) is presenting over 40 groundbreaking innovations. These include advanced AI-powered technologies aimed at optimizing patient care and enhancing…
Bayer has inaugurated Bayer Co.Lab Berlin, a state-of-the-art life science incubator located at the company’s Pharmaceuticals Division Global Headquarters Campus. Positioned near leading research and clinical institutions in Berlin, the new facility aims to foster innovation by providing startups with…
BeiGene has announced that the European Commission has approved TEVIMBRA® (tislelizumab) in combination with chemotherapy as a first-line treatment for two aggressive cancer types: esophageal squamous cell carcinoma (ESCC) and gastric or gastroesophageal junction (G/GEJ) adenocarcinoma. This decision is based…
Dr. Reddy’s Laboratories Ltd has announced the launch of Toripalimab in India, marking a significant advancement in the treatment of nasopharyngeal carcinoma (NPC). Toripalimab, a New Biological Entity (NBE), is the first and only immuno-oncology drug approved by regulatory agencies…